Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

2.

Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions

3.

Modified personalized cancer vaccine generates powerful immune response

4.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

5.

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot